GO:0002318 myeloid progenitor cell differentiation: Myeloid Lineage Commitment, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002318 describes the process by which a precursor cell acquires the specialized features of a myeloid progenitor cell, the founder cell type for granulocyte, monocyte, macrophage, dendritic cell and related myeloid lineages.
• Myeloid progenitor differentiation is a continuous, transcriptionally heterogeneous process rather than a series of discrete binary switches, as shown by single-cell regulatory mapping of human hematopoiesis.
• Lineage-restricted progenitors such as granulocyte-monocyte progenitors (GMPs) and monocyte-dendritic cell progenitors (MDPs) arise from this process and independently produce functionally distinct monocytes.
• Tissue-resident macrophage specification is developmentally programmed during organogenesis, linking myeloid progenitor differentiation to embryonic patterning.
• Dysregulation of myeloid progenitor differentiation can fuel immunosuppressive macrophage populations in tumors, connecting this GO term directly to cancer immunology.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with single-cell and library screening approaches, are central tools for dissecting this process.
Description
GO:0002318, myeloid progenitor cell differentiation, is the biological process in which a precursor cell type acquires the specialized features of a myeloid progenitor cell, a cell that can give rise to any of the myeloid lineages. Myeloid progenitors sit at a critical branch point in hematopoiesis, downstream of hematopoietic stem cells and upstream of committed granulocytic, monocytic, macrophage and dendritic cell fates. Understanding this process is therefore fundamental to immunology, hematology and cancer biology, because the number, identity and functional state of myeloid progenitors shape innate immune responses and tissue homeostasis. Historically, myeloid progenitor differentiation was viewed as a stepwise progression through discrete progenitor compartments defined by surface markers and colony-forming assays. Integrated single-cell analysis has since revealed a continuous regulatory landscape in which chromatin accessibility, transcription factor activity and gene expression change progressively along differentiation trajectories. This continuous view is reinforced by single-cell transcriptomic studies showing substantial transcriptional heterogeneity and asynchronous lineage commitment within populations classically labeled as myeloid progenitors. Because myeloid progenitor differentiation sits at the intersection of developmental biology, immunology and oncology, it is a frequent target of functional genomics research. Researchers use CRISPR screens, reporter models and single-cell multi-omics to identify the transcription factors, cytokine receptors and signaling modules that control progenitor self-renewal versus differentiation. The sections below summarize the definition, mechanism, key genes, disease links and experimental methods relevant to GO:0002318, based strictly on published literature.
myeloid progenitor cell differentiation At A Glance
| GO ID | GO:0002318 |
|---|---|
| GO term | myeloid progenitor cell differentiation |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Definition | The process in which a precursor cell type acquires the specialized features of a myeloid progenitor cell; myeloid progenitor cells include progenitor cells for any of the myeloid lineages. |
| Major function | Generation of lineage-restricted myeloid progenitors that seed granulocytic, monocytic, macrophage and dendritic cell development |
| Cell types produced | Granulocyte-monocyte progenitors, monocyte-dendritic cell progenitors and related myeloid-restricted progenitors |
| Key regulatory layer | Transcription factor networks and chromatin accessibility changes along continuous differentiation trajectories |
| Disease relevance | Tumor-associated immunosuppressive macrophage generation and myeloid dysregulation in cancer |
What Is GO:0002318?
In practical terms, GO:0002318 covers the cellular events through which a precursor cell becomes a myeloid progenitor cell. A myeloid progenitor is a cell that has acquired the specialized features required to produce one or more of the myeloid lineages, including granulocytes, monocytes, macrophages and dendritic cells. The term is therefore broader than the differentiation of any single mature myeloid cell type: it describes the acquisition of progenitor identity itself, encompassing the transcriptional, epigenetic and signaling changes that commit a precursor toward myeloid potential while retaining proliferative and multi-lineage capacity.
Why Is myeloid progenitor cell differentiation Important in Cell Biology?
Myeloid progenitor cell differentiation is important because it determines the supply of innate immune cells and shapes inflammatory, anti-microbial and anti-tumor responses. Perturbations in this process can expand immunosuppressive myeloid populations in tumors, as shown for dysregulated myeloid progenitors that fuel immunosuppressive macrophages. Because the process is continuous and transcriptionally heterogeneous, it also provides a tractable system for studying how transcription factor dosage, chromatin state and cytokine signaling jointly control cell fate decisions.
• Defines the founder cell population for all myeloid lineages, including granulocytes, monocytes, macrophages and dendritic cells.
• Provides a model system for studying continuous versus discrete cell fate decisions during hematopoiesis.
• Links developmental hematopoiesis to embryonic organogenesis through tissue-resident macrophage specification.
• Underlies the generation of functionally distinct monocyte subsets from separate progenitor compartments.
• Is directly implicated in cancer immunology through dysregulated progenitors that produce immunosuppressive macrophages.
• Is modulated by cytokine receptor signaling, making it amenable to engineered receptor approaches.
• Can be influenced by inflammatory mediators such as iNOS during neutrophil differentiation.
• Serves as a benchmark process for single-cell multi-omic trajectory inference and regulatory network reconstruction.
• Offers candidate targets for therapeutic modulation of myeloid cell output in inflammatory and neoplastic disease.
What Happens During myeloid progenitor cell differentiation?
Acquisition of myeloid progenitor identity
In simple terms: A precursor cell gradually turns on the gene program that makes it a myeloid progenitor.
During GO:0002318, a precursor cell acquires the specialized features of a myeloid progenitor, meaning it becomes capable of producing cells of the myeloid lineages. This transition involves coordinated changes in transcription factor activity and chromatin accessibility that establish myeloid potential while retaining proliferative capacity. Single-cell regulatory mapping of human hematopoietic differentiation shows that this acquisition occurs along a continuous landscape rather than as a single switch.
Transcriptional heterogeneity and lineage commitment
In simple terms: Even cells that look alike can be at different points along the path to becoming a specific myeloid cell.
Myeloid progenitor populations display substantial transcriptional heterogeneity, and lineage commitment occurs asynchronously within populations that share surface markers. This heterogeneity means that commitment to granulocytic, monocytic or dendritic fates is distributed across a continuum of progenitor states rather than confined to discrete compartments. Single-cell approaches are therefore required to resolve the regulatory events that define GO:0002318.
Emergence of lineage-restricted progenitors
In simple terms: From the general myeloid progenitor pool, more specialized progenitors emerge that are already biased toward certain cell types.
Myeloid progenitor differentiation gives rise to lineage-restricted progenitors such as granulocyte-monocyte progenitors (GMPs) and monocyte-dendritic cell progenitors (MDPs). These progenitors are not simply intermediates: GMPs and MDPs independently produce functionally distinct monocytes, indicating that the differentiation process generates parallel rather than strictly linear outputs. This branching architecture is a key feature of myeloid progenitor biology.
Specification of tissue-resident macrophage programs
In simple terms: Some myeloid progenitors are already programmed to become macrophages that live in specific organs.
Myeloid progenitor differentiation is linked to the specification of tissue-resident macrophages during organogenesis, when developmental cues instruct macrophage identity in a tissue-specific manner. This developmental specification occurs in parallel with organ formation, indicating that myeloid progenitor output is integrated with embryonic patterning. The process therefore has implications beyond immunology, extending into developmental biology.
Cytokine receptor signaling and proliferation control
In simple terms: Signals from cytokine receptors tell myeloid progenitors whether to multiply or to mature.
Cytokine receptor signaling sequentially controls proliferation and differentiation of myeloid cells, and engineered cytokine receptor-based chimeric antigen receptors can modulate these outputs. This indicates that the balance between progenitor expansion and differentiation is tunable through receptor-proximal signaling. Inflammatory mediators such as iNOS can also influence myeloid progenitor differentiation, as shown for neutrophil differentiation.
Key Genes Involved in GO:0002318 myeloid progenitor cell differentiation
The genes and proteins most relevant to GO:0002318 include transcription factors, cytokine receptors, signaling mediators and inflammatory enzymes that together control myeloid progenitor identity and output.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPI1 (PU.1) | Master myeloid transcription factor controlling progenitor identity | Central regulator of myeloid versus lymphoid fate decisions |
| CEBPA | Transcription factor promoting granulocytic and monocytic differentiation | Frequently studied in myeloid differentiation and leukemia models |
| GATA2 | Transcription factor maintaining hematopoietic progenitor programs | Implicated in progenitor state maintenance and lineage priming |
| IRF8 | Transcription factor controlling monocyte and dendritic cell progenitor fates | Distinguishes MDP and monocyte-dendritic lineages |
| KLF4 | Transcription factor modulating monocyte and macrophage differentiation | Used to study monocyte subset specification |
| CSF1R | Receptor for macrophage colony-stimulating factor | Controls monocyte and macrophage progenitor survival and differentiation |
| CSF2RB | Shared cytokine receptor subunit for GM-CSF and IL-5 signaling | Engineered receptor studies show control of proliferation and differentiation |
| MPO | Myeloperoxidase expressed in granulocytic progenitors | Marker of granulocytic progenitor commitment |
| ELANE | Neutrophil elastase expressed during granulocytic differentiation | Marker and functional gene in granulocytic progenitor maturation |
| LYZ | Lysozyme expressed in monocytic progenitors | Marker of monocytic lineage commitment |
| ITGAM (CD11b) | Integrin marking myeloid progenitor and mature myeloid cells | Surface marker used to isolate and track progenitors |
| FCGR3 (CD16) | Fc receptor expressed on mature myeloid subsets | Used to distinguish monocyte and macrophage maturation states |
| NOS2 (iNOS) | Inducible nitric oxide synthase influencing myeloid differentiation | Shown to augment neutrophil differentiation when overexpressed in progenitors |
| KIT (CD117) | Receptor tyrosine kinase marking hematopoietic progenitors | Used to define and isolate myeloid progenitor populations |
| FLT3 | Receptor tyrosine kinase marking early myeloid progenitors | Distinguishes progenitor subsets with dendritic cell potential |
| PTPRC (CD45) | Pan-leukocyte phosphatase | Common marker for hematopoietic and myeloid progenitor identification |
How Is myeloid progenitor cell differentiation Regulated?
Myeloid progenitor cell differentiation is regulated at multiple levels. Chromatin accessibility changes along continuous differentiation trajectories provide a permissive landscape for lineage-specific transcription factors. Cytokine receptor signaling sequentially controls proliferation and differentiation, and engineered cytokine receptor-based chimeric antigen receptors can reprogram these outputs. Inflammatory mediators such as iNOS can modulate differentiation toward neutrophils. Transcriptional heterogeneity within progenitor populations further shapes the timing and direction of commitment.
myeloid progenitor cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SPI1 (PU.1) | Myeloid lineage commitment and leukemia biology | Knockout and point-mutation models in hematopoietic cell lines |
| CSF2RB | Cytokine signaling imbalance affecting myeloid output | Engineered cytokine receptor knock-in models |
| NOS2 (iNOS) | Inflammatory modulation of neutrophil differentiation | Overexpression in myeloid progenitor cells |
| IRF8 | Monocyte and dendritic cell progenitor specification | Knockout models to assess MDP and monocyte output |
| KIT (CD117) | Progenitor maintenance and myeloid dysregulation | Tagged knock-in reporter for progenitor tracking |
Myeloid progenitor dysregulation in cancer
Dysregulated myeloid progenitors can fuel immunosuppressive macrophage populations in tumors, linking GO:0002318 to tumor immunology and potential therapeutic targeting. This connection suggests that interventions altering myeloid progenitor differentiation could reshape the tumor microenvironment.
Myeloid differentiation and inflammatory disease
Because cytokine receptor signaling controls the balance between myeloid progenitor proliferation and differentiation, perturbations in these pathways can alter inflammatory cell output. Inflammatory mediators such as iNOS also influence differentiation toward neutrophils, indicating that inflammation and myeloid progenitor differentiation are reciprocally connected.
Developmental and tissue-resident macrophage disorders
Specification of tissue-resident macrophages during organogenesis depends on developmental cues acting on myeloid progenitors, so defects in this process could affect tissue macrophage populations. This links GO:0002318 to developmental and tissue homeostasis disorders.
From myeloid progenitor cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate transcription factor required for myeloid progenitor identity? | CRISPR knockout in hematopoietic progenitor cell lines or primary cells |
| Does a specific point mutation alter progenitor differentiation potential? | CRISPR point-mutation knock-in at the endogenous locus |
| Can a reporter track myeloid progenitor states in real time? | Tagged knock-in of fluorescent reporter at a progenitor marker locus |
| Does overexpression of an inflammatory mediator shift differentiation? | Overexpression of NOS2 in myeloid progenitor cells |
| Can engineered cytokine receptors reprogram proliferation versus differentiation? | Chimeric antigen receptor knock-in in myeloid progenitors |
| Which genes regulate the continuous differentiation trajectory? | CRISPR library screening combined with single-cell readouts |
How to Study the myeloid progenitor cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptional heterogeneity and differentiation trajectories | Mapping continuous myeloid progenitor differentiation |
| Single-cell ATAC-seq | Chromatin accessibility dynamics | Identifying regulatory elements driving progenitor commitment |
| CRISPR knockout screening | Gene requirement for progenitor differentiation | Discovering regulators of myeloid progenitor output |
| CRISPR point-mutation knock-in | Effect of specific variants on differentiation | Testing disease-associated or functional residues |
| Tagged knock-in reporters | Real-time tracking of progenitor states | Monitoring differentiation in live cells |
| Overexpression assays | Gain-of-function effects on differentiation | Testing inflammatory mediators such as iNOS |
| Engineered cytokine receptor assays | Proliferation versus differentiation signaling | Dissecting receptor-proximal control of myeloid output |
| Flow cytometry with surface markers | Progenitor and mature myeloid cell frequencies | Isolating and quantifying progenitor populations |
Single-cell transcriptomics and trajectory inference
Single-cell RNA sequencing resolves transcriptional heterogeneity within myeloid progenitor populations and enables trajectory inference across continuous differentiation landscapes. These methods are essential because commitment occurs asynchronously and cannot be fully captured by bulk assays.
Chromatin accessibility profiling
Assays such as ATAC-seq map regulatory element accessibility along hematopoietic differentiation and reveal how chromatin state changes accompany myeloid progenitor differentiation. Integrated single-cell analysis combining chromatin and transcriptome data provides a continuous regulatory landscape of human hematopoietic differentiation.
Functional perturbation with CRISPR screens
CRISPR knockout and library screening approaches identify genes required for myeloid progenitor differentiation and can be coupled to single-cell readouts to resolve trajectory-specific effects. These screens are particularly useful for discovering regulators that act at specific points along the differentiation continuum.
Engineered receptor and cytokine signaling assays
Cytokine receptor-based chimeric antigen receptors can be introduced into myeloid progenitors to test how receptor signaling sequentially controls proliferation and differentiation. Such assays help dissect the signaling logic that governs progenitor expansion versus maturation.
How CRISPR Can Be Used to Study GO:0002318 myeloid progenitor cell differentiation
Knockout
CRISPR knockout of candidate transcription factors or signaling genes in hematopoietic progenitor cells can test whether they are required for myeloid progenitor differentiation. Knockout screens have been used to identify regulators acting along continuous differentiation trajectories.
Point Mutation
CRISPR point-mutation knock-in allows precise testing of whether specific residues or variants alter myeloid progenitor differentiation potential without confounding effects of complete gene loss. This is particularly useful for dissecting transcription factor dosage effects.
Knock-in
Tagged knock-in of fluorescent reporters at progenitor marker loci enables real-time tracking of myeloid progenitor states and purification of defined populations for downstream analysis. Knock-in of engineered cytokine receptors can also reprogram proliferation and differentiation outputs.
Overexpression
Overexpression of inflammatory mediators such as NOS2 in myeloid progenitor cells can shift differentiation toward neutrophils, demonstrating gain-of-function effects on GO:0002318. Overexpression models complement loss-of-function approaches by revealing sufficiency of a gene for differentiation outcomes.
How EDITGENE Supports myeloid progenitor cell differentiation Research
Researchers studying myeloid progenitor cell differentiation-related genes often need to determine whether a candidate gene is causally involved in progenitor identity, lineage commitment or disease-associated dysregulation. Establishing causality requires precise genetic perturbation in relevant cellular models, combined with readouts that resolve the continuous and heterogeneous nature of this process. EDITGENE provides the CRISPR-based tools and screening services needed to build such models and interrogate GO:0002318 systematically.
Contact EDITGENE today to design your custom CRISPR model for myeloid progenitor cell differentiation research.
Frequently Asked Questions About myeloid progenitor cell differentiation
What is GO:0002318?
GO:0002318 is the Gene Ontology biological process term for myeloid progenitor cell differentiation, defined as the process in which a precursor cell type acquires the specialized features of a myeloid progenitor cell, which can give rise to any of the myeloid lineages.
What is myeloid progenitor cell differentiation?
It is the developmental process by which a precursor cell becomes a myeloid progenitor capable of producing granulocytes, monocytes, macrophages and dendritic cells, occurring along a continuous regulatory landscape rather than as a single switch.
What genes are involved in myeloid progenitor cell differentiation?
Key genes include SPI1 (PU.1), CEBPA, GATA2, IRF8, KLF4, CSF1R, CSF2RB, MPO, ELANE, LYZ, ITGAM, KIT, FLT3 and NOS2, which together control progenitor identity, lineage commitment and differentiation output.
Why is myeloid progenitor cell differentiation important in cancer?
Dysregulated myeloid progenitors can fuel immunosuppressive macrophage populations in tumors, making this process relevant to cancer immunology and therapeutic targeting.
How is myeloid progenitor cell differentiation studied?
It is studied using single-cell RNA-seq, single-cell ATAC-seq, CRISPR knockout and point-mutation models, tagged knock-in reporters, overexpression assays and engineered cytokine receptor systems.
What are granulocyte-monocyte progenitors?
Granulocyte-monocyte progenitors (GMPs) are lineage-restricted progenitors that arise during myeloid progenitor differentiation and, together with monocyte-dendritic cell progenitors, independently produce functionally distinct monocytes.
Are myeloid progenitor cells the same as hematopoietic stem cells?
No. Myeloid progenitor cells are downstream of hematopoietic stem cells and have acquired specialized features that restrict them toward myeloid lineages, as described by GO:0002318.
What role does cytokine receptor signaling play in myeloid progenitor differentiation?
Cytokine receptor signaling sequentially controls proliferation and differentiation of myeloid cells, and engineered cytokine receptor-based chimeric antigen receptors can modulate these outputs.
Can CRISPR be used to study myeloid progenitor cell differentiation?
Yes. CRISPR knockout, point-mutation knock-in, tagged knock-in and overexpression models, as well as CRISPR library screens, are widely used to dissect the regulators of this process.
What diseases are linked to myeloid progenitor cell differentiation?
Dysregulation of this process is linked to tumor-associated immunosuppressive macrophage generation, inflammatory signaling imbalances and developmental specification of tissue-resident macrophages.
Conclusion
GO:0002318, myeloid progenitor cell differentiation, defines the process by which precursor cells acquire the specialized features of myeloid progenitors that seed granulocytic, monocytic, macrophage and dendritic cell lineages. Research over the past decade has shown that this process is continuous, transcriptionally heterogeneous and shaped by transcription factor networks, chromatin accessibility and cytokine receptor signaling. Its dysregulation is directly relevant to cancer immunology and inflammatory disease, making it a high-value target for functional genomics. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with single-cell and library screening approaches, provide the experimental toolkit needed to dissect this process with precision. EDITGENE supports researchers in building these models and in analyzing the resulting data to advance understanding of myeloid progenitor biology.
References
- 1. Hegde S et al.. 2025. Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours.. Nature 646(8087):1214-1222 PMID: 40931076
- 2. Buenrostro JD et al.. 2018. Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation.. Cell 173(6):1535-1548.e16 PMID: 29706549
- 3. Mass E et al.. 2016. Specification of tissue-resident macrophages during organogenesis.. Science 353(6304) PMID: 27492475
- 4. Geissmann F et al.. 2010. Development of monocytes, macrophages, and dendritic cells.. Science 327(5966):656-61 PMID: 20133564
- 5. Yáñez A et al.. 2017. Granulocyte-Monocyte Progenitors and Monocyte-Dendritic Cell Progenitors Independently Produce Functionally Distinct Monocytes.. Immunity 47(5):890-902.e4 PMID: 29166589
- 6. Paul F et al.. 2015. Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors.. Cell 163(7):1663-77 PMID: 26627738
- 7. Sadaf S et al.. 2019. Augmentation of iNOS expression in myeloid progenitor cells expedites neutrophil differentiation.. J Leukoc Biol 106(2):397-412 PMID: 30861597
- 8. Nakajima K et al.. 2022. Sequential control of myeloid cell proliferation and differentiation by cytokine receptor-based chimeric antigen receptors.. PLoS One 17(12):e0279409 PMID: 36574389
